Combining LABA and ICS in patients with severe COPD Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- January 1, 2007
has subject area
- 1102 Cardiorespiratory Medicine and Haematology (FoR)
- 1103 Clinical Sciences (FoR)
- 1117 Public Health and Health Services (FoR)
- Administration, Inhalation (MeSH)
- Adrenergic beta-Agonists (MeSH)
- Albuterol (MeSH)
- Anti-Asthmatic Agents (MeSH)
- Asthma (MeSH)
- Bronchodilator Agents (MeSH)
- Cardiovascular System & Hematology (Science Metrix)
- Clinical Trials as Topic (MeSH)
- Drug Therapy, Combination (MeSH)
- Dyphylline (MeSH)
- Glucocorticoids (MeSH)
- Humans (MeSH)
- Pulmonary Disease, Chronic Obstructive (MeSH)
- Quality of Life (MeSH)
- Severity of Illness Index (MeSH)
- Survival Analysis (MeSH)
- Treatment Outcome (MeSH)